Bladder Cancer Market Trends, Size, Competitive Analysis and Forecast 2021-2027

1. Orion Market Research Bladder Cancer Market, Size, Share, Analysis Report & Forecast to 2027 To Request a Sample of our Report on Bladder Cancer Market: https://www.omrglobal.com/request- sample/bladder-cancer-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The global bladder cancer market is projected to grow at a considerable CAGR of 5.2% during the forecast period. The main cause of bladder cancer includes the consumption of tobacco products includes cigarettes, cigars, pipes, chewing tobacco, and snuff. Moreover, extensive exposure to chemicals, past harmful radiation exposure, and parasitic infections are other factors that contributing to the growth of the market. Additionally, having a family history of bladder cancer, having certain changes in the genes that are linked to bladder cancer, and Past treatment with radiation therapy or certain anticancer drugs, such as cyclophosphamide or ifosfamide. The increasing prevalence of smoking and tobacco consumption has a major impact on the growth of the bladder cancer market across the globe. Changing the lifestyle of people is a significant cause of bladder cancer. Unhealthy eating activity is increasing among people, which is a major risk for bladder cancer. As per the American Lung Association, the average smoker smokes 15 cigarettes per day in the US. Similar trends can be observed in other countries of Europe and China, and Australia. (Get 15% Discount on Buying this Report) A full Report of Bladder Cancer Market is Available at: https://www.omrglobal.com/industry- reports/bladder-cancer-market As per World Health Organization (WHO), there are 1.1 billion people consume tobacco across the globe. Smokers are 4 to 7 times more likely to develop bladder cancer than non-smokers. Bladder cancer is the tenth most common cancer across the globe. In 2018, there were 17 million new cases of bladder cancer across the globe. As per Cancer Research UK, the incidence of cancer is estimated to reach 62% during 2018-2040 across the globe. Bladder cancer is considered the fourth common cancer in men whereas it is the least common cancer in women. As per the American Cancer Society, there will be an estimated 80,470 new cases in the US in 2019. Out of this, 61,700 new cases will be associated with male and 18,770 will be associated with the female. For instance, in March 2016 the National Cancer Institute has invested $5.5 million in establishing laboratories to advance research on biomarkers and biomarker assays for several cancers. Market players can engage with these organizations so as expand their product offerings in the coming years. Market Coverage • The market number available for – 2021-2027 • Base year- 2020 • Forecast period- 2021-2027 Segment Covered- • By Cancer type • By Diagnosis Method • By Therapy Regions Covered- • North America • Europe • Asia-Pacific • Rest of the World Key questions addressed by the report •What is the market growth rate? •Which segment and region dominate the market in the base year? •Which segment and region will project the fastest growth in the market?

3. •How COVID-19 impacted the market? Deviation from the pre-COVID-19 forecast Most affected region and segment •Who is the leader in the market? •How players are addressing challenges to sustain growth? •Where is the investment opportunity? To Request a Sample of our Report on Bladder Cancer Market: https://www.omrglobal.com/request- sample/bladder-cancer-market o o Global Bladder Cancer Market Report Segment By Cancer type •Transitional Cell Bladder Cancer/ Urothelial Carcinoma •Squamous Cell Bladder Cancer •Adenocarcinoma •Other Rare Types (Sarcomas, Carcinoma in Situ) By Diagnosis Method •Cystoscopy •Biopsy •Urinalysis •Urine Cytology •Intravenous Pyelogram (Ivp) •Other By Therapy •Chemotherapy •Immunotherapy •Radiation Therapy •Surgery •Other Global Bladder Cancer Market Report Segment by Region North America •United States •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe Asia-Pacific •India

4. •China •Japan •Rest of APAC Rest of The World • • Latin America Middle East & Africa Company Profile • • • • • • • • • • • • • • • AstraZeneca PLC Bristol-Myers Squibb Co. Celgene Corp. Eli Lilly And Co. Endo International Plc Epocrates, Inc. GlaxoSmithKline Plc Hoffmann-La Roche Ltd. Johnson & Johnson Services, Inc. Merck & Co., Inc. Merck KGaA Novartis International AG Nucleix Ltd. Pfizer Inc. Spectrum Pharmaceuticals, Inc. Reasons for Buying from us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/bladder-cancer-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari

5. Email: info@omrglobal.com Contact no: +91 7803040404